China Pharma (US:CPHI) Jing Ji Guan Cha Wang·2026-02-11 22:58Company Overview - Recent significant stock price fluctuations were observed, with a 6.98% increase on January 8, reaching $1.38, followed by a 6.27% decrease on January 9, closing at $1.27. The maximum volatility during this period was 5.43%, with generally low trading volumes (e.g., 2,359 shares), indicating limited market activity [2]. - The latest financial report shows total revenue of $756,217, a net loss of $651,482, earnings per share of -$0.17, and a negative gross margin of -$257,612 [3]. Industry Context - The pharmaceutical industry experienced relatively minor fluctuations during the same period, with the industry index rising by 0.19% on January 9. However, the company's performance diverged significantly from the overall industry trend [4]. Future Outlook - The company is in a state of ongoing losses and has a small equity base, making its stock price susceptible to short-term market sentiments. Investors should monitor upcoming financial reports and changes in industry policies [5].